R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Total Rewards Manager

Compensation & BenefitsConfirmed live in the last 24 hours
Full-timeTokyo, JapanIn-person

About the Job

Requirements

  • A bachelor's degree or equivalent practical experience in Human Resources, Business, Finance, or a related field.
  • At least 7 years of progressive Human Resources or Total Rewards experience, including hands-on experience with compensation and benefits programs.
  • Strong knowledge of compensation principles, market benchmarking, salary structures, incentive programs, benefits administration, and related Total Rewards practices.
  • Working knowledge of the Japanese employment environment and compliance considerations relevant to compensation and benefits programs.
  • Ability to interpret data, evaluate options, and make sound recommendations within established policies and business objectives.
  • Ability to collaborate across functions and gain cooperation on sensitive or complex matters.
  • Accuracy, judgment, discretion, and confidentiality when handling employee and compensation information.
  • Native-level Japanese language proficiency.
  • Business-level English proficiency, including the ability to participate in meetings, communicate with global stakeholders, and review business documents in English.

Responsibilities

  • Lead Total Rewards activities in Japan, including compensation, benefits, recognition, and related programs.
  • Translate global and functional Total Rewards plans into practical local processes, timelines, communications, and operating procedures for Japan.
  • Manage annual compensation processes, including salary review, short-term incentive planning, market benchmarking, pay analysis, and recommendations to support internal equity and external competitiveness.
  • Support the administration and communication of equity and other long-term incentive programs in partnership with global Total Rewards and relevant internal stakeholders.
  • Oversee employee benefit programs and vendor relationships in Japan; review program effectiveness, service quality, employee experience, cost, and market competitiveness.
  • Ensure Total Rewards programs and practices are administered in accordance with applicable Japanese laws, regulations, tax and social insurance considerations, internal policies, and company governance requirements, in partnership with appropriate subject-matter experts.
  • Provide data-driven analysis and recommendations to Human Resources and business leaders on compensation, benefits, workforce cost, and related Total Rewards matters.
  • Partner with HR Business Partners, Talent Acquisition, Finance, Payroll, Legal, and global Total Rewards colleagues to support hiring, retention, organizational changes, and business planning.
  • Manage external consultants, brokers, and other vendors as needed, including scope, deliverables, timelines, service levels, and costs.
  • Identify opportunities to improve Total Rewards processes, tools, controls, documentation, and employee communications, and lead implementation of agreed improvements.
  • Handle sensitive employee and compensation information with discretion, integrity, and appropriate confidentiality.

Desired Qualifications

  • Experience in a biotechnology, pharmaceutical, life sciences, or other fast-growing global organization.
  • Experience working in a global or U.S.-headquartered company and partnering across time zones and cultures.
  • Experience with equity compensation, job architecture or leveling, compensation survey tools, and HR information systems.
  • Professional certification in compensation, benefits, or Human Resources, such as CCP or equivalent.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs